Xconomy Boston

Cequent Pharmaceuticals, Inc. Garners $4,500,000 New Financing Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=e661692a-8cc9-4a3a-bf21-11f3794d2dda&Preview=1
Date
2/7/2008
Company Name
Cequent Pharmaceuticals, Inc.
Mailing Address
One Kendall Square, Building 700, First Floor Cambridge, MA 02139
Company Description
Cequent Pharmaceuticals, Inc. is an early-stage biopharmaceutical company developing new clinically compatible therapies based on RNA interference (RNAi). Cequent is focusing its efforts on the pre-clinical development of products to treat gastrointestinal diseases, including familial polyposis, inflammatory bowel disease and colon cancer.
Website
http://www.cequentpharma.com
Transaction Type
Venture Equity
Transaction Amount
$4,500,000
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds purposes were not disclosed.
M&A Terms
Venture Investor
Undisclosed